Goh SY, Kosiborod MN, Lam CSP, Cavender MA, et al. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. Diabetes Obes Metab 2023;25:2402-2409.
PMID: 37055714